What question did this study set out to answer?

The viewpoint aims to explore the role of real-world evidence in Medicare's drug price negotiations.

December 8, 2025JAMA

Real-World Evidence for Medicare Drug Price Negotiations

View Full Paper

Ask AI

Bookmark

The viewpoint aims to explore the role of real-world evidence in Medicare's drug price negotiations.
Discussion of the potential application of real-world evidence studies.
Analysis of current Medicare drug price negotiation processes.
Highlights how aligning spending with value could improve efficiency in drug price negotiations.

Implication

This viewpoint discusses how real-world evidence can enhance drug price negotiations for Medicare, aligning costs with value.

Abstract

This Viewpoint discusses how real-world evidence studies could help the US Centers for Medicare & Medicaid Services align spending with value in their drug price negotiations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Colleen Carey (2025) studied this question.

synapsesocial.com/papers/693624ce4fa91c937236cdae https://doi.org/10.1001/jama.2025.21498

View Full Paper

Ask AI

Bookmark

Implication

This viewpoint discusses how real-world evidence can enhance drug price negotiations for Medicare, aligning costs with value.

Abstract

This Viewpoint discusses how real-world evidence studies could help the US Centers for Medicare & Medicaid Services align spending with value in their drug price negotiations.

Real-World Evidence for Medicare Drug Price Negotiations

Key Points

Implication

Abstract

Discussion

Cite This Study

Real-World Evidence for Medicare Drug Price Negotiations

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading